WHO = World Health Organization advisory committee said that there is "no reason not to recommend vaccination" for the new coronavirus vaccine developed by pharmaceutical giant AstraZeneca and others, and it is effective against the mutant virus confirmed in South Africa. He emphasized that the benefits of vaccination outweigh the risks, while some view it as limited.
South Africa says that vaccines developed by British pharmaceutical giant AstraZeneca and others may be less effective in preventing mild to moderate symptoms against the mutant virus confirmed in South Africa as a result of early clinical trials. The government has temporarily suspended the start of vaccination.
The advisory board that advises WHO on vaccination held a press conference on the 10th, and Chairman Clavioto said that the vaccine was effective in preventing mild to moderate symptoms against the mutant virus confirmed in South Africa as a result of clinical trials. Decreased significantly, but did not have enough samples to assess the risk of aggravation.
"There is no reason not to recommend vaccination in countries where the mutant virus is widespread, even if it does not have a complete preventive effect," he said, recommending that each country should proceed as planned.
In addition, there are a series of moves to refrain from vaccination in Europe, saying that there is insufficient efficacy data for elderly people aged 65 and over regarding this vaccine, but Dr. Hongbak, who oversees the secretariat of the advisory committee, said He pointed out that the elderly should also be vaccinated, saying that the immune response of the elderly is almost the same as that of the younger age group.
In addition, lead scientist Swaminasan emphasized that the benefits of vaccination outweigh the risks, saying that AstraZeneca's vaccine could be the first vaccine available in many countries as the infection spreads. ..